Premarket trading on Wednesday showed a generally upbeat tone, reflecting a modest rebound after the previous day’s declines. On the New York Stock Exchange (NYSE), about 65% of listed stocks (1,190) were in positive territory, while 380 stocks (20%) traded lower and 251 remained unchanged.

Over on the Nasdaq, roughly 61% of shares (2,016) advanced, 29% (957) declined, and 306 held steady with no notable movement.

Biggest movers on the NYSE

Leading the NYSE premarket gainers was NetSTREIT Corp (NYSE:NTST), a commercial real estate management firm, which climbed 14.81%. It was followed by Select Medical Holdings Corporation (NYSE:SEM), a major hospital operator, up 10.20%, and SES AI Corporation (NYSE:SES), a battery manufacturer, which gained 8.86%.

On the downside, the largest premarket losses were seen in Joby Aviation Inc (NYSE:JOBY), a company specializing in air mobility, which dropped 10.89%. Vicarious Surgical Inc (NYSE:RBOT), a robotics developer, declined 9.04%, and Redwire Corporation (NYSE:RDW), an aerospace components supplier, slipped 7.75%.

Biggest movers on the Nasdaq

On the Nasdaq, the standout premarket performer was Xenetic Biosciences Inc (NASDAQ:XBIO), a biotechnology firm that skyrocketed 171.10%. AlphaTON Capital Corporation (NASDAQ:ATON), an investment company, followed with a 138.53% surge, while Nexalin Technologies Inc (NASDAQ:NXL), a maker of medical devices, jumped 95.05%.

The steepest declines came from Zeta Network Group (NASDAQ:ZNB), a blockchain technology company that fell 41.47%. Galecto Inc (NASDAQ:GLTO), a biopharmaceutical firm, lost 40.90%, and Envoy Medical Inc (NASDAQ:COCH), which develops hearing devices, dropped 38.27%.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Some portions of this content may have been generated or assisted by artificial intelligence (AI) tools and been reviewed for accuracy and quality by our editorial team.